Product Details
Synonyms
ABPP, APPI, Amyloid-beta A4 protein
Source
Human Abeta40 (672-711) Protein, His Tag (APP-H51H9) is expressed from E. coli cells. It contains AA Asp 672 - Val 711 (Accession # P05067-1).
Predicted N-terminus: Met
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 6.3 kDa. The protein migrates as 9-10 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Purity
>95% as determined by SDS-PAGE.
Formulation
Lyophilized from 0.22 μm filtered solution in 20 mM NaOH with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Shipping and Storage
This product is shipped at ambient temperature.
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
Customers Also Viewed
Performance Data
SDS-PAGE

Human Abeta40 (672-711) Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).
Bioactivity-ELISA

Immobilized Human Abeta40 (672-711) Protein, His Tag (Cat. No. APP-H51H9) at 5 μg/mL (100 μL/well) can bind Biosimilar Aducanumab with a linear range of 0.06-2 ng/mL (QC tested).
Protocol
Customer Reviews Writing Reviews

Background
Recent Advances
- English Name:
Beta amyloid A4 protein
- Category:
- Approved Drugs:
13 Details
- Drugs in Clinical Trials:
54 Details
- Highest Development Stage:
Approved



















